PreventionGenetics Introduces Rapid PGxomeⓇ Whole Exome Sequencing Test for $2290

Published on

Marshfield, WI - PreventionGenetics is excited to introduce Rapid PGxome to their menu of whole exome sequencing (WES) tests. Rapid PGxome is WES with an expedited average turnaround time of 14 days and a cost starting at $2290. In cases with a clear positive result, a preliminary report may be issued as soon as six days. Rapid PGxome is ideal for situations where a rapid genetic diagnosis is essential, including patients with neonatal, infantile or early childhood onset severe disorders.

PreventionGenetics Partners with the Little Zebra Fund to Provide Clinical Genetic Tests

Published on

MARSHFIELD, Wis., April 8, 2019 -- PreventionGenetics today announced a partnership with the Little Zebra Fund, a non-profit organization dedicated to providing access to clinical genetic testing for patients in the San Francisco Bay Area. The organization was founded by two physicians who specialize in making rare diagnoses and recognize the value of genetic testing in ending the diagnostic odyssey.  The Little Zebra Fund offers financial assistance to qualified patients for genetic testing; funds must be requested by a healthcare provider.

PreventionGenetics Celebrates 15 Year Anniversary

Published on

Marshfield, WI - Founded in 2004 by James Weber, PhD, a world renowned research scientist, PreventionGenetics announced their 15th anniversary of providing clinical DNA testing. PreventionGenetics began as a small genetic testing laboratory in Central Wisconsin, and has grown to become a leader in clinical DNA testing and DNA banking. PreventionGenetics has tested hundreds of thousands of patient specimens from around the world. The tests offered by PreventionGenetics are medically actionable, affecting treatment or medical management.

PreventionGenetics announces integration with FDNA's deep learning platform, Face2Gene to increase the diagnostic power of genetic testing

Published on

November 29, 2017, Marshfield, WI – PreventionGenetics today announces integration of their genetic testing and interpretation services with FDNA’s ( Face2Gene suite of applications ( 

The integration with Face2Gene increases the diagnostic power of PreventionGenetics’ genetic testing using artificial intelligence and computer vision technology, which highlights genetic variants that are highly correlated with disease and the patient’s clinical phenotype. 

PreventionGenetics Releases Genetic Tests for Infertility

Published on

Marshfield, WI – PreventionGenetics has launched new genetic tests for both female and male infertility. Infertility affects 10-20% of couples worldwide and is generally attributed to males and females equally. It is estimated that genetic abnormalities including both chromosomal and single-gene alterations can account for up to 30% of cases of infertility (Hotaling 2014).